Metabolic myopathies discovered during investigations of statin myopathy.
Baker
Steven K
SK
Vladutiu
Georgirene D
GD
Peltier
Wendy L
WL
Isackson
Paul J
PJ
Tarnopolsky
Mark A
MA
D000368:Aged; D000483:Alleles; D003402:Creatine Kinase / Q000097:blood; D004247:DNA / Q000235:genetics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D008297:Male; D008659:Metabolic Diseases / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism*; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced* / Q000235:genetics / Q000378:metabolism*; D009154:Mutation / Q000502:physiology; D009460:Neurologic Examination; D017035:Pravastatin / Q000009:adverse effects; D017368:Protein Prenylation / Q000187:drug effects; D011725:Pyridines / Q000009:adverse effects
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D004247:DNA; C086276:cerivastatin; D003402:Creatine Kinase; D017035:Pravastatin